Treating Nasal Congestion May Prevent Asthma Attacks

Published Online: Saturday, June 1, 2002

The use of intranasal corticosteroids to treat an upper airways condition (rhinitis, sinusitis, or otitis media) appears to lower the risk for emergency department (ED) visits for acute asthma exacerbations, according to findings published in the Journal of Allergy and Clinical Immunology. In fact, the number of ED visits was 30% lower among people with asthma who received intranasal corticosteroids, compared with those who were untreated. This rate reduction was found even after the researchers adjusted for age, sex, frequency of orally inhaled corti-costeroid and beta-agonist dispensing, amount and type of ambulatory care for asthma, and diagnosis of an upper airways condition. The risk reduction was even greater?50%?among patients with more than 3 intranasal corticosteroid prescriptions dispensed per year.

Latest Articles
This weekly video program highlights the latest in pharmacy news, product news, and more.
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Latest Issues